Senior Lecturer in Paediatric Brain Tumour Epigenetics at Queen Mary University of London

HomeHealth & Fitness

Senior Lecturer in Paediatric Brain Tumour Epigenetics at Queen Mary University of London

my-portfolio

[ad_1] About the RoleThe Senior Lecturer will contribute to the intellectual life of the Brain Tumour Centre, Institute, wider institu

Research Fellow in Health Data Science at University of Surrey
Research Manager at MRC Laboratories, The Gambia
Clinical Senior Lecturer in Paediatric Dentistry at University of Bristol

[ad_1]

About the Role
The Senior Lecturer will contribute to the intellectual life of the Brain Tumour Centre, Institute, wider institution and the research field of paediatric brain tumours with focus on the characterisation of epigenetic dysregulation in these tumours to develop molecularly tailored therapies aimed at enhancing efficacy of treatment whilst reducing side effects, hence improving prognosis and quality of life for children affected by a brain tumour. They will make contributions to student education and experience through curriculum development and the delivery of teaching activities in the subject area of neuro-oncology, cancer, stem cells and developmental neurobiology.

About You
The successful candidate will have a PhD in Molecular Oncology, Molecular Medicine, or a related discipline. They will have a proven track record of high-quality research in the field of epigenetics of paediatric brain tumours and clear and ambitious plans for future research. They will have experience in teaching at undergraduate and/or postgraduate level, experience with developing and delivery of research-led teaching, and successful supervision of PhD students.

About the Institute
The Blizard Institute was established in 2003 and is one of six Institutes within the Faculty of Medicine and Dentistry, QMUL. The Institute comprises approximately 360 staff based in four academic Centres and one Public Engagement Centre, and supports a combined total of c750 postgraduate research and taught students. The Institute aims to deliver excellence in all aspects of research, teaching and clinical service.

About Queen Mary
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.

Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.

We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.

Benefits
We offer competitive salaries, access to a generous pension scheme, 30 days’ leave per annum (pro-rata for part-time/fixed-term), a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies, flexible working arrangements, and campus facilities including an on-site nursery at the Mile End campus.

The post is based at the Whitechapel Campus in London. It is a full-time, permanent appointment, with an expected start date of September 2023. The starting salary will be Grade 7, in the range of £60,128 – £67,139 per annum, inclusive of London Allowance.

Queen Mary’s commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability. We are open to considering applications from candidates wishing to work flexibly.

Informal enquiries should be addressed to Professor Silvia Marino at s.marino@qmul.ac.uk.

To apply for the role, please click the ‘Apply’ button.

The closing date for applications is 20 June 2023.

Interviews are expected to be held shortly thereafter.

[ad_2]

Source link

COMMENTS

WORDPRESS: 0
DISQUS: